Sandra Levy
ARTICLES BY THIS AUTHOR
- 12/1/2019
CVS Health encourages families to get flu shots
Flu shots are available seven days a week at CVS Pharmacy and MinuteClinic locations nationwide. - 12/1/2019
Mylan, Biocon launch Herceptin biosimilar Ogivri
Mylan's Ogivri is available in 420 mg multidose vials and 150 mg single-dose vials. - 12/1/2019
Breckenridge gets FDA clearance for generic Exelon Patch
The Exelon Patch and its generics had a market value of $161 million for the 12 months ended Sept. 30, 2019. - 12/1/2019
Cumberland gets FDA nod for RediTrex
Cumberland's RediTrex injection is a treatment for adult and pediatric patients with rheumatoid arthritis, as well as adults with psoriasis. - 11/24/2019
Shionogi & Co. gets FDA green light for Fetroja
The FDA has approved a new antibacterial drug to treat complicated UTIs. - 11/24/2019
FDA approves Zai Lab partner, GSK’s expanded indication for Zejula
Zejula is now the only, once-daily PARP inhibitor approved as monotherapy treatment for recurrent ovarian cancer beyond those with a BRCA mutation in both the recurrent maintenance and late-line treatment settings. - 11/21/2019
Dr. Reddy's debuts generic Hectorol
Hectorol injection single-dose vials and multidose vials brand and generics had a market value of approximately $138 million for the most recent 12 months ending in September 2019, according to IQVIA. - 11/21/2019
SK Life Science gets FDA OK for Xcopri
The FDA has approved Xcopri, a new treatment for adults with partial-onset seizures. - 11/20/2019
60 Degrees Pharmaceuticals launching Arakoda
Arakoda, the first antimalarial product approved by the Food and Drug Administration for the prevention of malaria, is being made available at select pharmacies and wholesalers. - 11/20/2019
FDA approves new indication of AstraZeneca's Calquence
As part of an international collaboration, the FDA has approved AstraZeneca's new treatment option for patients with chronic lymphocytic leukemia.
